Fueled by a handful of trials and word-of-mouth buzz, low-dose naltrexone is gaining momentum among patients and some doctors ...

See related article at Key points In this issue’s research article, Rebić and colleagues show that rates of opioid prescribing across 6 Canadian provinces declined gradually from 2018 to 2022, with n ...

The drug, one of the few nonhormonal options for menopausal women, reduced hot flashes and night sweats, and appears to help ...

If approved, it would be the first major new drug treatment for Parkinson’s in half a century. Richard Mailman, a University ...

Corticosteroid + long-acting beta-2 agonist (LABA). Allow approx. 12hrs between doses. Asthma: ≥12yrs: initially 1 inh of 100/50 or 250/50 or 500/50 twice daily, based on disease severity and previous ...